The metabolic arm of KYN is shifted towards KYNA by the action of RO 61-8048, which is a KMO inhibitor, thereby elevating KYNA levels and ameliorating dyskinesia in MPTP monkeys with LID [102]. The gene discussed is KMO; the disease is drug-induced dyskinesia.